Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Smith

Showing results (91-100 of 303) with videos related to

Pageof 31
Sort By:
AJSP: Reviews & Reports|July 14, 2020
B-Lymphoid Blast Phase of Chronic Myeloid Leukemia: A Case Report and Review of the LiteratureAlisha D Ware, Laura Wake, Patrick Brown, et al.
Plos One|June 2, 2021
Biochemical characterization of a recombinant acid phosphatase from Acinetobacter baumanniiElizabeth Smiley-Moreno, Douglas Smith, Jieh-Juen Yu, et al.
Leukemia & Lymphoma|October 27, 2021
Risk factors for severe infections in secondary immunodeficiency: a retrospective US administrative claims study in patients with hematological malignanciesStephen Jolles, B Douglas Smith, Donald C Vinh, et al.
Leukemia Research|November 21, 2020
Expression of putative leukemia stem cell targets in genetically-defined acute myeloid leukemia subtypesBreann Yanagisawa, Brandy Perkins, Theodoros Karantanos, et al.
Head and Neck Pathology|February 22, 2021
Myeloid Neoplasm with PDGFRA Rearrangement Manifesting as a Retromolar Pad MassAmy S Duffield, Jonathan Webster, B Douglas Smith, et al.
Journal of Child Neurology|January 4, 2011
Assessing autonomic dysfunction symptoms in children: a pilot studyXue Ming, Jennifer M Bain, Douglas Smith, et al.
British Journal of Haematology|October 30, 2016
A phase 2 trial of high dose lenalidomide in patients with relapsed/refractory higher-risk myelodysplastic syndromes and acute myeloid leukaemia with trilineage dysplasiaAmer M Zeidan, B Douglas Smith, Hetty E Carraway, et al.
Current Medical Research and Opinion|March 23, 2018
Developing an instrument to assess patient preferences for benefits and risks of treating acute myeloid leukemia to promote patient-focused drug developmentJaein Seo, B Douglas Smith, Elihu Estey, et al.
The Journal of Rheumatology|April 1, 2009
Resident evaluations: the use of daily evaluation forms in rheumatology ambulatory careSusan Humphrey-Murto, Nader Khalidi, C Douglas Smith, et al.
Leukemia & Lymphoma|April 10, 2014
The evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: can tyrosine kinase inhibitors replace donor lymphocyte infusions?Joshua F Zeidner, Marianna Zahurak, Gary L Rosner, et al.
Pageof 31

Showing results (91-100 of 303) with videos related to

Sort By:
Pageof 31
AJSP: Reviews & Reports|July 14, 2020
B-Lymphoid Blast Phase of Chronic Myeloid Leukemia: A Case Report and Review of the LiteratureAlisha D Ware, Laura Wake, Patrick Brown, et al.
Plos One|June 2, 2021
Biochemical characterization of a recombinant acid phosphatase from Acinetobacter baumanniiElizabeth Smiley-Moreno, Douglas Smith, Jieh-Juen Yu, et al.
Leukemia & Lymphoma|October 27, 2021
Risk factors for severe infections in secondary immunodeficiency: a retrospective US administrative claims study in patients with hematological malignanciesStephen Jolles, B Douglas Smith, Donald C Vinh, et al.
Leukemia Research|November 21, 2020
Expression of putative leukemia stem cell targets in genetically-defined acute myeloid leukemia subtypesBreann Yanagisawa, Brandy Perkins, Theodoros Karantanos, et al.
Head and Neck Pathology|February 22, 2021
Myeloid Neoplasm with PDGFRA Rearrangement Manifesting as a Retromolar Pad MassAmy S Duffield, Jonathan Webster, B Douglas Smith, et al.
Journal of Child Neurology|January 4, 2011
Assessing autonomic dysfunction symptoms in children: a pilot studyXue Ming, Jennifer M Bain, Douglas Smith, et al.
British Journal of Haematology|October 30, 2016
A phase 2 trial of high dose lenalidomide in patients with relapsed/refractory higher-risk myelodysplastic syndromes and acute myeloid leukaemia with trilineage dysplasiaAmer M Zeidan, B Douglas Smith, Hetty E Carraway, et al.
Current Medical Research and Opinion|March 23, 2018
Developing an instrument to assess patient preferences for benefits and risks of treating acute myeloid leukemia to promote patient-focused drug developmentJaein Seo, B Douglas Smith, Elihu Estey, et al.
The Journal of Rheumatology|April 1, 2009
Resident evaluations: the use of daily evaluation forms in rheumatology ambulatory careSusan Humphrey-Murto, Nader Khalidi, C Douglas Smith, et al.
Leukemia & Lymphoma|April 10, 2014
The evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: can tyrosine kinase inhibitors replace donor lymphocyte infusions?Joshua F Zeidner, Marianna Zahurak, Gary L Rosner, et al.
Pageof 31